Sign In

Christopher Waldmann

PhD, Head Radiochemist at Department of Nuclear Medicine, Universitätsmedizin Mainz

Christopher Waldmann is an experienced radiochemist, researcher, and lab manager with a strong background in academia and the healthcare system. He holds a Doctor of Philosophy degree and has worked in various roles related to radiochemistry and radiopharmaceutical development.3

Dr. Waldmann's career highlights include:

  1. Current position: Radiochemist and Advisor at Universitätsmedizin Mainz (2021-present)2
  2. Previous role: Head of Radiochemistry at Universitätsmedizin Mainz (2018-2021)2
  3. Postdoctoral Researcher at UCLA's Crump Institute for Molecular Imaging, where he invented the HetSiFA® technology1
  4. Chief Scientific Officer at Fuzionaire Theranostics4

His research focuses on the development of radiopharmaceuticals for theranostic applications in oncology.1 Dr. Waldmann has authored a chapter in the textbook "Molecular Imaging in Oncology" and his work has been published in leading academic journals including Theranostics, PNAS, and Nature.1

Dr. Waldmann's expertise in radiopharmaceutical manufacturing and development spans over a decade, making him a valuable contributor to the field of nuclear medicine and molecular imaging.1

Highlights

Molecular Imaging of Hydrolytic Enzymes Using PET and SPECT

Related Questions

What are Christopher Waldmann's main research interests in radiochemistry?
How has Christopher Waldmann contributed to the field of nuclear medicine?
What projects has Christopher Waldmann worked on at Universitätsmedizin Mainz?
Can you provide examples of Christopher Waldmann's publications?
What is Christopher Waldmann's educational background?
Christopher Waldmann
Christopher Waldmann, photo 1
Christopher Waldmann, photo 2
Add to my network

Location

Mainz, Rhineland-Palatinate, Germany